These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 36384524)

  • 1. Nanomaterials: small particles show huge possibilities for cancer immunotherapy.
    Chen Z; Yue Z; Yang K; Li S
    J Nanobiotechnology; 2022 Nov; 20(1):484. PubMed ID: 36384524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterials: A powerful tool for tumor immunotherapy.
    Chen Z; Yue Z; Wang R; Yang K; Li S
    Front Immunol; 2022; 13():979469. PubMed ID: 36072591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterials: leading immunogenic cell death-based cancer therapies.
    Ma C; Cheng Z; Tan H; Wang Y; Sun S; Zhang M; Wang J
    Front Immunol; 2024; 15():1447817. PubMed ID: 39185425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Nanotechnology-Based Immunotherapy for Glioblastoma.
    Tang L; Zhang M; Liu C
    Front Immunol; 2022; 13():882257. PubMed ID: 35651605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of ICD via Nanotechnology.
    Qin Y; Zhang H; Li Y; Xie T; Yan S; Wang J; Qu J; Ouyang F; Lv S; Guo Z; Wei H; Yu CY
    Macromol Biosci; 2023 Sep; 23(9):e2300093. PubMed ID: 37114599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing Cancer Chemo-Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials.
    Wang J; Li L; Xu ZP
    Small Methods; 2024 Jan; 8(1):e2301005. PubMed ID: 37743260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-activated nanomaterials for tumor immunotherapy.
    Wang F; Duan H; Xu W; Sheng G; Sun Z; Chu H
    Front Chem; 2022; 10():1031811. PubMed ID: 36277335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based Nanomaterials in the Immunotherapy.
    Huang H; Gao S; Cai X
    Curr Drug Metab; 2023; 24(5):367-384. PubMed ID: 37069706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Nanomaterials for Cancer Immunotherapy.
    Li J; Lu W; Yang Y; Xiang R; Ling Y; Yu C; Zhou Y
    Adv Sci (Weinh); 2023 Feb; 10(6):e2204932. PubMed ID: 36567305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials for cancer immunotherapy.
    Song W; Musetti SN; Huang L
    Biomaterials; 2017 Dec; 148():16-30. PubMed ID: 28961532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Advanced are Cancer Immuno-Nanotherapeutics? A Comprehensive Review of the Literature.
    Yadav D; Puranik N; Meshram A; Chavda V; Lee PC; Jin JO
    Int J Nanomedicine; 2023; 18():35-48. PubMed ID: 36636642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress of nanovaccine in anti-tumor immunotherapy.
    Yao M; Liu X; Qian Z; Fan D; Sun X; Zhong L; Wu P
    Front Oncol; 2023; 13():1211262. PubMed ID: 37692854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.
    Guo L; Yang J; Wang H; Yi Y
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications.
    Ji T; Zhao Y; Ding Y; Nie G
    Adv Mater; 2013 Jul; 25(26):3508-25. PubMed ID: 23703805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology for next-generation cancer immunotherapy: State of the art and future perspectives.
    Chen Y
    J Control Release; 2023 Apr; 356():14-25. PubMed ID: 36805873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimuli-Responsive Nanomaterials for Tumor Immunotherapy.
    Li XP; Hou DY; Wu JC; Zhang P; Wang YZ; Lv MY; Yi Y; Xu W
    ACS Biomater Sci Eng; 2024 Sep; 10(9):5474-5495. PubMed ID: 39171865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterials: Breaking through the bottleneck of tumor immunotherapy.
    Kang Y; Li S
    Int J Biol Macromol; 2023 Mar; 230():123159. PubMed ID: 36610572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy.
    Chen Z; Yue Z; Yang K; Shen C; Cheng Z; Zhou X; Li S
    Adv Healthc Mater; 2023 Oct; 12(26):e2300882. PubMed ID: 37539730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-based products for cancer immunotherapy.
    Shams F; Golchin A; Azari A; Mohammadi Amirabad L; Zarein F; Khosravi A; Ardeshirylajimi A
    Mol Biol Rep; 2022 Feb; 49(2):1389-1412. PubMed ID: 34716502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.